Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Proctor

Showing results (221-230 of 293) with videos related to

Pageof 30
Sort By:
Toxicology and Applied Pharmacology|December 14, 2011
Genome-wide gene expression effects in B6C3F1 mouse intestinal epithelia following 7 and 90days of exposure to hexavalent chromium in drinking waterAnna K Kopec, Suntae Kim, Agnes L Forgacs, et al.
WMJ : Official Publication of the State Medical Society of Wisconsin|October 24, 2000
Antibiotic susceptibility of invasive Streptococcus pneumoniae in Wisconsin, 1999E A Belongia, M Proctor, M Vandermause, et al.
Chemico-Biological Interactions|September 18, 2012
Physiologically based pharmacokinetic model for rats and mice orally exposed to chromiumC R Kirman, S M Hays, L L Aylward, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 5, 2017
High-Throughput Screening Data Interpretation in the Context of In Vivo Transcriptomic Responses to Oral Cr(VI) ExposureJulia E Rager, Caroline L Ring, Rebecca C Fry, et al.
Science Advances|June 26, 2021
Electronics with shape actuation for minimally invasive spinal cord stimulationBen J Woodington, Vincenzo F Curto, Yi-Lin Yu, et al.
Environmental and Molecular Mutagenesis|May 27, 2015
Assessment of the mutagenic potential of Cr(VI) in the oral mucosa of Big Blue® transgenic F344 ratsChad M Thompson, Robert R Young, Mina Suh, et al.
British Journal of Cancer|March 1, 1995
The use of granulocyte colony-stimulating factor to deliver four cycles of ifosfamide and epirubicin every 14 days in women with advanced or metastatic breast cancerM J Lind, L Gumbrell, B M Cantwell, et al.
Critical Reviews in Toxicology|November 4, 2020
An adverse outcome pathway for small intestinal tumors in mice involving chronic cytotoxicity and regenerative hyperplasia: a case study with hexavalent chromium, captan, and folpetVirunya S Bhat, Samuel M Cohen, Elliot B Gordon, et al.
Advanced Materials (Deerfield Beach, Fla.)|August 16, 2013
Tri-diketopyrrolopyrrole molecular donor materials for high-performance solution-processed bulk heterojunction solar cellsJianhua Liu, Yanming Sun, Preecha Moonsin, et al.
Cancer Treatment Reviews|January 1, 1993
Long-term oral etoposide in metastatic breast cancer: clinical and pharmacokinetic resultsA H Calvert, M J Lind, M M Millward, et al.
Pageof 30

Showing results (221-230 of 293) with videos related to

Sort By:
Pageof 30
Toxicology and Applied Pharmacology|December 14, 2011
Genome-wide gene expression effects in B6C3F1 mouse intestinal epithelia following 7 and 90days of exposure to hexavalent chromium in drinking waterAnna K Kopec, Suntae Kim, Agnes L Forgacs, et al.
WMJ : Official Publication of the State Medical Society of Wisconsin|October 24, 2000
Antibiotic susceptibility of invasive Streptococcus pneumoniae in Wisconsin, 1999E A Belongia, M Proctor, M Vandermause, et al.
Chemico-Biological Interactions|September 18, 2012
Physiologically based pharmacokinetic model for rats and mice orally exposed to chromiumC R Kirman, S M Hays, L L Aylward, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 5, 2017
High-Throughput Screening Data Interpretation in the Context of In Vivo Transcriptomic Responses to Oral Cr(VI) ExposureJulia E Rager, Caroline L Ring, Rebecca C Fry, et al.
Science Advances|June 26, 2021
Electronics with shape actuation for minimally invasive spinal cord stimulationBen J Woodington, Vincenzo F Curto, Yi-Lin Yu, et al.
Environmental and Molecular Mutagenesis|May 27, 2015
Assessment of the mutagenic potential of Cr(VI) in the oral mucosa of Big Blue® transgenic F344 ratsChad M Thompson, Robert R Young, Mina Suh, et al.
British Journal of Cancer|March 1, 1995
The use of granulocyte colony-stimulating factor to deliver four cycles of ifosfamide and epirubicin every 14 days in women with advanced or metastatic breast cancerM J Lind, L Gumbrell, B M Cantwell, et al.
Critical Reviews in Toxicology|November 4, 2020
An adverse outcome pathway for small intestinal tumors in mice involving chronic cytotoxicity and regenerative hyperplasia: a case study with hexavalent chromium, captan, and folpetVirunya S Bhat, Samuel M Cohen, Elliot B Gordon, et al.
Advanced Materials (Deerfield Beach, Fla.)|August 16, 2013
Tri-diketopyrrolopyrrole molecular donor materials for high-performance solution-processed bulk heterojunction solar cellsJianhua Liu, Yanming Sun, Preecha Moonsin, et al.
Cancer Treatment Reviews|January 1, 1993
Long-term oral etoposide in metastatic breast cancer: clinical and pharmacokinetic resultsA H Calvert, M J Lind, M M Millward, et al.
Pageof 30